References
- Collaborative Normal-Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol199812644985059780094
- LeskeMCHeijlAHusseinMBengtssonBHymanLKomaroffEfor Early Manifest Glaucoma Trial GroupFactors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma TrialArch Ophthalmol20031211485612523884
- Advanced Glaucoma Intervention Study InvestigatorsThe Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol2000130442944011024415
- KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol2002120670171312049574
- IwaseASuzukiYAraieMfor Tajimi Study Group, Japan Glaucoma SocietyThe prevalence of primary open-angle glaucoma in Japanese: the Tajimi StudyOphthalmology200411191641164815350316
- YamamotoTIwaseAAraieMfor Tajimi Study Group, Japan Glaucoma SocietyThe Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese populationOphthalmology2005112101661166916111758
- AraieMKitazawaYLong-term efficacy and safety of 0.03% bimatoprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertensionAtarashii Ganka201128812091215 Japanese
- SatoSHirookaKBabaTEfficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucomaJ Ocul Pharmacol Ther201127549950221790301
- NakanoTYoshikawaKKimuraTSuzumuraHNannoMNoroTEfficacy and safety of tafluprost in normal-tension glaucoma with intraocular pressure of 16 mmHg or lessJpn J Ophthalmol201155660561321874307
- LempMAReport of the National Eye Institute/Industry workshop on clinical trials in dry eyesCLAO J19952142212328565190
- YamazakiSNannoMKimuraTSuzumuraHYoshikawaKEffects of switching to SofZia-preserved travoprost in patients who presented with superficial punctate keratopathy while under treatment with latanoprostJpn J Ophthalmol201054171420151269
- ChengJWWeiRLMeta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressureClin Ther200830462263218498911
- FiscellaRWaltJEstimated comparative costs of achieving a 20% reduction in intraocular pressure with bimatoprost or latanoprost in patients with glaucoma or ocular hypertensionDrugs Aging2006231394716492068
- GandolfiSSimmonsSTSturmRChenKVanDenburghAMfor Bimatoprost Study Group 3Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertensionAdv Ther200118311012111571823
- IkedaYMoriKIshibashiTNaruseSNakajimaNKinoshitaSLatanoprost nonresponders with open-angle glaucoma in the Japanese populationJpn J Ophthalmol200650215315716604392
- KurtzSMannOIncidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprostEur J Ophthalmol200919340040319396785
- HonrubiaFGarcía-SánchezJPoloVde la CasaJMSotoJConjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trialsBr J Ophthalmol200993331632119019922
- NoeckerRJHerrygersLAAnwaruddinRCorneal and conjunctival changes caused by commonly used glaucoma medicationsCornea200423549049615220734
- FilippopoulosTPaulaJSTorunNHattonMPPasqualeLRGrosskreutzCLPeriorbital changes associated with topical bimatoprostOphthal Plast Reconstr Surg2008244302307